Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (GB:0KW4)
LSE:0KW4
Resmed (0KW4) Share Price & Analysis
1 Followers
0KW4 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$131.91 - $237.56
Previous Close$215.85
Volume10.63K
Average Volume (3M)3.59K
Market Cap
$32.07B
Enterprise Value$33.26B
Total Cash (Recent Filing)$210.25M
Total Debt (Recent Filing)$1.39B
Price to Earnings (P/E)33.2
Beta1.16
Next Earnings
Aug 01, 2024EPS Estimate
$2.08Next Dividend Ex-Date
May 08, 2024Dividend Yield1.02%
Share Statistics
EPS (TTM)6.50
Shares Outstanding146,907,207
10 Day Avg. Volume21
30 Day Avg. Volume3,588
Standard Deviation0.07
R-Squared0.00427
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)29.38
Price to Sales (P/S)7.01
Price to Cash Flow (P/CF)29.40
P/FCF Ratio30.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.30
Enterprise Value/Gross Profit14.12
Enterprise Value/Ebitda23.95
Forecast
1Y Price Target
$215.57Price Target Upside0.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Resmed News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRMD's revenue and non-GAAP EPS have surpassed consensus estimates, indicating the company's financial momentum.
Healthcare ImpactClinical data suggests that patients using RMD's products may experience higher rates of sleep apnea remission, potentially increasing product demand and patient outcomes.
Market Share & Product DemandRMD is well-positioned to sustain significant US market share gains, which could further enhance earnings potential.
Bears Say
Company Legal IssuesPhilips has agreed on the final terms of the CPAP consent decree which includes a permanent injunction on new CPAP sales.
Market RiskUpcoming SURMOUNT-OSA study data release could cause near term share price volatility.
Regulatory ChallengesThe consent decree terms reflect FDA's view of Philips having multiple violations, including failure to address prior violations and continued violative manufacturing practices.
---
Options Prices
Currently, No data available
---
Ownership Overview
2.71% Insiders
21.78% Mutual Funds
24.00% Other Institutional Investors
51.50% Public Companies and
Individual Investors
0KW4 FAQ
What was Resmed’s price range in the past 12 months?
Resmed lowest share price was $131.91 and its highest was $237.56 in the past 12 months.
What is Resmed’s market cap?
Currently, no data Available
When is Resmed’s upcoming earnings report date?
Resmed’s upcoming earnings report date is Aug 01, 2024 which is in 93 days.
How were Resmed’s earnings last quarter?
Resmed released its earnings results on Apr 25, 2024. The company reported $2.13 earnings per share for the quarter, beating the consensus estimate of $1.927 by $0.203.
Is Resmed overvalued?
According to Wall Street analysts Resmed’s price is currently Undervalued.
Does Resmed pay dividends?
Resmed pays a Quarterly dividend of $0.48 which represents an annual dividend yield of 1.02%. See more information on Resmed dividends here
What is Resmed’s EPS estimate?
Resmed’s EPS estimate is $2.08.
How many shares outstanding does Resmed have?
Resmed has 147,088,880 shares outstanding.
What happened to Resmed’s price movement after its last earnings report?
Resmed reported an EPS of $2.13 in its last earnings report, beating expectations of $1.927. Following the earnings report the stock price went up 19.169%.
Which hedge fund is a major shareholder of Resmed?
Among the largest hedge funds holding Resmed’s share is Greenvale Capital LLP. It holds Resmed’s shares valued at 95M.
---
Resmed Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$215.57 (0.09% Upside)
$215.57 (0.09% Upside)
Blogger Sentiment
Bullish
GB:0KW4 Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $5.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.61%
12-Months-Change
Fundamentals
Return on Equity
22.39%
Trailing 12-Months
Asset Growth
1.50%
Trailing 12-Months
Company Description
Resmed
Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).
---
0KW4 Company Deck
---
0KW4 Earnings Call
Q3 2024
0:00 / 0:00
---
0KW4 Revenue Breakdown
53.77% Devices
34.44% Masks and other
11.79% Software as a Service
---
0KW4 Stock 12 Months Forecast
Average Price Target
$215.57
▲(0.09% Upside)
Technical Analysis
Best Analysts Covering 0KW4
1 Year
1 Year Success Rate
9/13 ratings generated profit
1 Year Average Return
+10.99%
reiterated a buy rating 4 days ago
Copying Lyanne Harrison's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +10.99% per trade.
---